We are live on ! Find out more
Fayez Sarofim & Co

Fayez Sarofim & Co Portfolio holdings

AUM $42.5B
1-Year Est. Return 18.19%
This Fund
S&P 500
This Quarter Est. Return
+0.3%
1 Year Est. Return
+18.19%
3 Year Est. Return
+63.85%
5 Year Est. Return
+89.78%
10 Year Est. Return
+309.54%
AUM
$41.1B
AUM Growth
+$1.81B
Cap. Flow
+$2.06B
Cap. Flow %
5%
Top 10 Hldgs %
42.56%
Holding
315
New
30
Increased
123
Reduced
65
Closed
3

Top Buys

Rank Stock Value
1
NVDA icon
NVIDIA
NVDA
+$267M
2
DE icon
Deere & Co
DE
+$139M
3
GOOG icon
Alphabet (Google) Class C
GOOG
+$117M
4
JPM icon
JPMorgan Chase
JPM
+$114M
5
CVX icon
Chevron
CVX
+$88.5M

Top Sells

Rank Stock Value
1
NVO
Novo Nordisk
NVO
+$90M
2
CMCSA icon
Comcast
CMCSA
+$36M
3
UNP icon
Union Pacific
UNP
+$19.2M
4
HES
Hess
HES
+$19.2M
5
KMPR icon
Kemper
KMPR
+$17.6M

Sector Composition

Rank Sector Weight
1 Technology 30.18%
2 Financials 18.99%
3 Healthcare 11.19%
4 Consumer Staples 11.19%
5 Energy 8.31%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
WES icon
226
Western Midstream Partners
WES
$19.5B
$565K ﹤0.01%
14,704
SEIC icon
227
SEI Investments
SEIC
$12.7B
$551K ﹤0.01%
6,675
ECL icon
228
Ecolab
ECL
$77B
$545K ﹤0.01%
2,326
IJJ icon
229
iShares S&P Mid-Cap 400 Value ETF
IJJ
$8.59B
$534K ﹤0.01%
4,276
+2,216
+108% +$283K
VZ icon
230
Verizon
VZ
$214B
$521K ﹤0.01%
13,020
+1,836
+16% +$77.5K
NEE icon
231
NextEra Energy
NEE
$169B
$515K ﹤0.01%
7,185
-1,000
-12% -$77.7K
IBKR icon
232
Interactive Brokers
IBKR
$40.2B
$511K ﹤0.01%
11,572
MFC icon
233
Manulife Financial
MFC
$72.7B
$479K ﹤0.01%
15,593
BSX icon
234
Boston Scientific
BSX
$63.6B
$478K ﹤0.01%
5,351
+1,558
+41% +$137K
VOO icon
235
Vanguard S&P 500 ETF
VOO
$1.04T
$476K ﹤0.01%
884
HAL icon
236
Halliburton
HAL
$29.7B
$464K ﹤0.01%
17,060
+520
+3% +$15.2K
GM icon
237
General Motors
GM
$74.9B
$457K ﹤0.01%
8,584
HUM icon
238
Humana
HUM
$47.6B
$457K ﹤0.01%
1,800
GLW icon
239
Corning
GLW
$124B
$451K ﹤0.01%
9,500
CYBR
240
DELISTED
CyberArk
CYBR
$449K ﹤0.01%
1,348
TSCO icon
241
Tractor Supply
TSCO
$17.2B
$445K ﹤0.01%
8,380
GPC icon
242
Genuine Parts
GPC
$18.1B
$438K ﹤0.01%
3,754
IWO icon
243
iShares Russell 2000 Growth ETF
IWO
$14.1B
$436K ﹤0.01%
1,514
+600
+66% +$177K
NWSA icon
244
News Corp Class A
NWSA
$16.3B
$433K ﹤0.01%
15,714
-1,000
-6% -$27.9K
NFLX icon
245
Netflix
NFLX
$324B
$430K ﹤0.01%
4,830
A icon
246
Agilent Technologies
A
$42.4B
$417K ﹤0.01%
3,101
CTAS icon
247
Cintas
CTAS
$79.6B
$415K ﹤0.01%
2,272
+400
+21% +$84.1K
ADM icon
248
Archer Daniels Midland
ADM
$41.7B
$394K ﹤0.01%
7,800
CLX icon
249
Clorox
CLX
$10.5B
$393K ﹤0.01%
+2,419
New +$396K
POOL icon
250
Pool Corp
POOL
$6.06B
$374K ﹤0.01%
1,096
-850
-44% -$310K

Similar funds

Fayez Sarofim & Co's Q4 2024 Portfolio in Review

As of Q4 2024, Fayez Sarofim & Co held 315 positions worth $41.1B, up 4.6% from $39.3B the previous quarter. Its ten largest holdings account for 43% of the portfolio.

Fayez Sarofim & Co deployed $2.06B of net new capital in Q4 2024, opening 30 new positions and adding to 123 existing holdings. Its largest new stake was Copart: 158,575 shares worth $9.1M.

By sector, the portfolio is most concentrated in Technology at 30% of assets, up from 29% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was Novo Nordisk, an estimated $90M trimmed.

  • Fayez Sarofim & Co's largest Q4 2024 buy was Copart: 158,575 shares worth $9.1M.
  • Fayez Sarofim & Co added most to NVIDIA in Q4 2024, an estimated $267M increase.
  • Fayez Sarofim & Co's biggest Q4 2024 reduction was Novo Nordisk, cutting an estimated $90M.
  • Fayez Sarofim & Co fully exited Bruker in Q4 2024, selling an estimated $227K.
  • Fayez Sarofim & Co's ten largest holdings make up 43% of its $41.1B portfolio in Q4 2024.
  • Fayez Sarofim & Co opened 30 new positions and closed 3 in Q4 2024.
  • Fayez Sarofim & Co's portfolio value rose 4.6% quarter-over-quarter to $41.1B.

Based on Fayez Sarofim & Co's 13F filing for Q4 2024, filed 14 Feb 2025.